Maxim Integrated Products (MXIM) 10-Q 29 Jan 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	6 Months Ended
	Dec. 28, 2019	Jan. 17, 2020
DEI [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common stock, $0.001 par value
Entity Incorporation, State or Country Code	DE
Entity File Number	1-34192
Entity Registrant Name	MAXIM INTEGRATED PRODUCTS, INC.
Entity Address, Address Line One	160 Rio Robles
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	601-1000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Central Index Key	0000743316
Trading Symbol	MXIM
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 28, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Entity Emerging Growth Company	false
Entity Small Business	false
Current Fiscal Year End Date	--06-27
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		269,394,184
Entity Tax Identification Number	94-2896096
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Jun. 29, 2019
Document Period End Date	Dec. 28, 2019
Finite-Lived Intangible Assets, Gross	$ 619,115	$ 616,325
Current assets:
Cash and cash equivalents	1,720,194	1,757,342
Short-term Investments	63,006	140,990
Total cash, cash equivalents and short-term investments	1,783,200	1,898,332
Allowance for Doubtful Accounts Receivable, Current	723	148
Accounts receivable, net	348,342	360,016
Inventories	223,958	246,512
Other assets current	23,797	34,640
Total current assets	2,379,297	2,539,500
Property, plant and equipment, net	571,359	577,722
Intangible assets, net	48,509	56,242
Goodwill	532,251	532,251
Other assets noncurrent	95,413	38,267
TOTAL ASSETS	3,626,829	3,743,982
Current liabilities:
Accounts payable	89,449	84,335
Price adjustment and other revenue reserves	105,237	100,490
Income taxes payable	38,307	33,765
Accrued salary and related expenses	94,739	118,704
Accrued expenses	32,739	33,873
Total current liabilities	360,471	371,167
Long term debt	993,303	992,584
Income taxes payable	433,743	469,418
Other liabilities	112,803	65,537
Total liabilities	1,900,320	1,898,706
Commitments and contingencies (Note 11)
Stockholders' equity:
Common stock and capital in excess of par value	270	272
Retained earnings	1,737,528	1,856,358
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,289)	(11,354)
Total stockholders' equity	1,726,509	1,845,276
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	3,626,829	3,743,982
Intellectual Property [Member]
Finite-Lived Intangible Assets, Gross	$ 490,136	$ 487,346

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Dec. 28, 2019	Jun. 29, 2019
Statement of Financial Position [Abstract]
Allowance for Doubtful Accounts Receivable, Current	$ 723	$ 148

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Interest Expense	$ 9,300	$ 11,700	$ 18,600	$ 24,600
Interest Expense, Debt	8,900	11,200	17,800	23,600
Allocated Share-based Compensation Expense	24,066	21,656	48,738	42,153
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,193	2,304	5,081	4,268
Allocated Share-based Compensation Expense, Net of Tax	21,873	19,352	43,657	37,885
Revenue from Contract with Customer, Excluding Assessed Tax	551,070	576,906	1,084,110	1,215,401
Net revenues	551,070	576,906	1,084,110	1,215,401
Cost of goods sold	190,546	203,858	380,263	412,117
Gross margin	360,524	373,048	703,847	803,284
Operating expenses:
Research and development	111,914	110,303	220,903	223,011
Selling, general and administrative	76,071	77,853	152,186	159,372
Intangible asset amortization	756	756	1,512	1,529
Impairment of long-lived assets	0	753	0	753
Severance and Restructuring Charges	2,728	1,179	4,162	2,173
Other operating expenses (income), net	(1)	0	24	60
Total operating expenses	191,468	190,844	378,787	386,898
Operating income	169,056	182,204	325,060	416,386
Interest and other income (expense), net	(17)	472	1,812	(74)
Income before provision for income taxes	169,039	182,676	326,872	416,312
Income tax provision	22,989	50,784	40,666	86,997
Net income	$ 146,050	$ 131,892	$ 286,206	$ 329,315
Earnings per share:
Basic	$ 0.54	$ 0.48	$ 1.06	$ 1.19
Diluted	$ 0.53	$ 0.47	$ 1.04	$ 1.17
Shares used in the calculation of earnings per share:
Basic	270,330	276,252	270,859	277,144
Diluted	273,269	280,008	273,884	281,414
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 64	$ 78	$ 144	$ 155
Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	20,940	19,350	42,658	37,447
ESP Plan [Member]
Allocated Share-based Compensation Expense	3,062	2,228	5,936	4,551
Cost of Sales [Member]
Allocated Share-based Compensation Expense	2,973	2,388	5,931	4,667
Cost of Sales [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	5	9	14	19
Cost of Sales [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	2,269	1,884	4,549	3,646
Cost of Sales [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	699	495	1,368	1,002
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	11,436	9,839	22,320	19,696
Research and Development Expense [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	4	11	8	22
Research and Development Expense [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	9,918	8,693	19,403	17,384
Research and Development Expense [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	$ 1,514	$ 1,135	$ 2,909	$ 2,290

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Statements of Income and Comprehensive Income [Abstract]
Net income	$ 146,050	$ 131,892	$ 286,206	$ 329,315
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $(3), $(201), $(17) and $(228), respectively	0	885	118	1,977
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $(117), $(96), $48 and $(310), respectively	610	423	(249)	1,518
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(20), $(18), $(42) and $(37), respectively	98	76	196	154
Other comprehensive income (loss), net	708	1,384	65	3,649
Total comprehensive income	146,758	133,276	286,271	332,964
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	(3)	(201)	(17)	(228)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	(117)	(96)	48	(310)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	$ (20)	$ (18)	$ (42)	$ (37)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($) shares in Thousands, $ / shares in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Shares, Outstanding		278,664
Accumulated Other Comprehensive Income (Loss), Net of Tax at Dec. 29, 2018	$ (11,336,000)				$ (11,336,000)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	329,315,000			$ 329,315,000
Other Comprehensive Income (Loss), Net of Tax	3,649,000
Shares of common stock repurchased		(5,822)
Value of common stock repurchased	(320,056,000)		$ 63,744,000	256,312,000
Adjustment to Retained Earnings ASU 2016-01	2,487,000			2,487,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures		578
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(13,444,000)		(13,444,000)
Stock Issued During Period, Shares, Other		522
Stock Issued During Period, Value, Stock Options Exercised	13,843,000		13,843,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	42,185,000		42,185,000
Adjustments to Additional Paid in Capital, Other	3,471,000		3,471,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans		384
Stock Issued During Period, Value, Employee Stock Purchase Plan	(17,689,000)		(17,689,000)
Dividends	0.92
Dividends, Common Stock, Cash	(254,665,000)	$ 0		(254,665,000)
Accumulated Other Comprehensive Income (Loss), Net of Tax at Jun. 29, 2019	(11,354,000)
Stockholders' Equity, Other	$ 1,845,276,000	272,000		1,856,358,000	(11,354,000)
Common Stock, Shares, Outstanding	274,326
Common Stock, Par or Stated Value Per Share		$ 279,000
Additional Paid in Capital	$ 0
Retained Earnings (Accumulated Deficit)				1,766,471,000
Common Stock, No Par Value	$ 279
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	$ 1,755,414,000
Shares, Outstanding		271,852
Stockholders' Equity, Other	1,781,286,000	$ 271,000		1,793,012,000	(11,997,000)
Accumulated Other Comprehensive Income (Loss), Net of Tax at Dec. 28, 2019	(11,289,000)				(11,289,000)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	286,206,000			286,206,000
Other Comprehensive Income (Loss), Net of Tax	65,000
Shares of common stock repurchased		(3,484)
Value of common stock repurchased	(201,509,000)	$ 2,000	58,556,000	142,951,000
Cumulative Effect of New Accounting Principle in Period of Adoption	(2,053,000)			(2,053,000)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures		657
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(17,566,000)		(17,566,000)
Stock Issued During Period, Shares, Other		316
Stock Issued During Period, Value, Stock Options Exercised	8,820,000		8,820,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	48,767,000		48,767,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans		402
Stock Issued During Period, Value, Employee Stock Purchase Plan	(18,535,000)		(18,535,000)
Dividends	0.96
Dividends, Common Stock, Cash	(260,032,000)			(260,032,000)
Shares, Outstanding		270,883
Accumulated Other Comprehensive Income (Loss), Net of Tax at Dec. 28, 2019	(11,289,000)				$ (11,289,000)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	146,050,000			146,050,000
Other Comprehensive Income (Loss), Net of Tax	708,000
Shares of common stock repurchased		(1,862)
Value of common stock repurchased	(107,957,000)	$ 1,000	36,321,000	71,635,000
Cumulative Effect of New Accounting Principle in Period of Adoption	(89,000)			(89,000)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures		270
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(7,623,000)		(7,623,000)
Stock Issued During Period, Shares, Other		50
Stock Issued During Period, Value, Stock Options Exercised	1,338,000		1,338,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	24,071,000		24,071,000
Adjustments to Additional Paid in Capital, Other			3,471,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans		402
Stock Issued During Period, Value, Employee Stock Purchase Plan	(18,535,000)		$ (18,535,000)
Dividends	0.48
Dividends, Common Stock, Cash	$ (129,810,000)			(129,810,000)
Shares, Outstanding		277,430
Common Stock, Shares, Outstanding	269,743
Common Stock, Par or Stated Value Per Share		$ 270,000
Additional Paid in Capital	$ 0
Retained Earnings (Accumulated Deficit)				$ 1,737,528,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	$ 1,726,509,000

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Shareholders' Equity Dividends (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Statement of Stockholders' Equity [Abstract]
Dividends	$ 0.48	$ 0.46	$ 0.96	$ 0.92

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018
Document Period End Date	Dec. 28, 2019
Other Operating Activities, Cash Flow Statement	$ (5,961)	$ (636)
Cash flows from operating activities:
Net income	286,206	329,315
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	48,738	42,153
Depreciation and amortization	48,008	57,994
Deferred taxes	(2,231)	(8,206)
Gain (Loss) on Disposition of Property Plant Equipment	489	2,896
Changes in assets and liabilities:
Accounts receivable	16,421	19,798
Inventories	22,583	3,497
Other assets	(55,820)	(6,587)
Accounts payable	4,844	2,401
Income taxes payable	(31,133)	33,261
Accrued salary and related expenses	(23,965)	(45,783)
Other liabilities	58,634	60
Net cash provided by (used in) operating activities	378,735	431,435
Cash flows from investing activities:
Purchases of property, plant and equipment	(34,301)	(30,913)
Proceeds from sale of property, plant and equipment	171	2
Proceeds from sale of available-for-sale securities	0	27,253
Proceeds from maturity of available-for-sale securities	78,067	718,554
Payment in connection with business acquisition, net of cash acquired	0	(2,949)
Purchases of available-for-sale securities	0	(214,587)
Purchases of private company investments	0	(906)
Other investing activities	(68)	0
Net cash provided by (used in) investing activities	43,869	496,454
Cash flows from financing activities:
Repayment of debt	0	(500,000)
Contingent consideration paid	(8,000)	(8,000)
Payments of Stock Issuance Costs	(17,566)	(13,444)
Proceeds from stock options exercised	8,820	13,843
Issuance of common stock under employee stock purchase program	18,535	17,689
Repurchase of common stock	(201,509)	(320,056)
Payments of Dividends	(260,032)	(254,665)
Net cash provided by (used in) financing activities	(459,752)	(1,064,633)
Net increase (decrease) in cash and cash equivalents	(37,148)	(136,744)
Cash and cash equivalents:
Beginning of period	1,757,342	1,543,484
End of period	1,720,194	1,406,740
Cash paid (refunded), net during the period for income taxes	63,692	60,946
Interest Paid, Excluding Capitalized Interest, Operating Activities		23,313
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	$ 12,360	$ 14,660

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 28, 2019
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the six months ended December 28, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 29, 2019 . The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal years 2019 and 2020 are 52-week fiscal years.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	6 Months Ended
	Dec. 28, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Pronouncements [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Recently Issued Accounting Pronouncements (i) New Accounting Updates Recently Adopted In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-02 (ASU 2016-02), Leases (Topic 842) . Topic 842 states that lessees will recognize a lease liability for the commitment to make lease payments and a right-of-use asset for the underlying asset, for the duration of the lease. The FASB also issued ASU 2018-10 and ASU 2018-11 which provide improvements to ASU 2016-02 and an additional transition method option, respectively. This transition method allows a Company to apply the new lease accounting standard on adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings. The Company adopted ASU 2016-02 in the first quarter of fiscal year 2020. The Company adopted the new standard using the modified retrospective method and electing the optional transition method practical expedient. Under the optional transition method, the Company recognized a cumulative-effect adjustment to the consolidated balance sheet and did not adjust comparative prior period information. The Company elected multiple practical expedients permitted: • the hindsight practical expedient, in which the Company elected to use hindsight up until the effective date in determining the lease term and assessing impairment of right-of-use assets; • the practical expedient package that allows the Company to carry forward its determination of whether a lease exists, the classification of a lease, and whether initial direct lease costs exist for purposes of transition to the new standard; and • the practical expedient to combine lease and non-lease components. The Company also elected an accounting policy in which it will not apply the recognition requirements to leases with an initial term of 12 months or less. Effective June 30, 2019, the first day of adoption, the Company recognized $61.0 million of operating lease right-of-use assets and $65.2 million of operating lease liabilities on its Consolidated Balance Sheet. The difference of $4.2 million was primarily due to deferred rent, partially offset by prepaid rent for leases that existed as of the date of adoption, which decreased the opening balance of lease right-of-use (ROU) assets. Updated Lease Accounting Policy The Company determines if an arrangement is, or contains, a lease at inception. ROU assets are recorded as other assets, short-term lease obligations are recorded as accrued expenses and long-term lease obligations are recorded as other liabilities on the Company's Consolidated Balance Sheet. The Company’s classes of assets include real estate leases, equipment leases, and vehicle leases. Lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. When discount rates implicit in leases cannot be readily determined, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Dec. 28, 2019
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components [Text Block]	BALANCE SHEET COMPONENTS Inventories consist of: December 28, June 29, (in thousands) Raw materials $ 13,222 $ 16,121 Work-in-process 142,551 160,273 Finished goods 68,185 70,118 Total inventories $ 223,958 $ 246,512 Property, plant and equipment, net, consist of: December 28, June 29, (in thousands) Land $ 17,720 $ 17,720 Buildings and building improvements 306,052 265,191 Machinery, equipment and software 1,338,349 1,367,606 Total 1,662,121 1,650,517 Less: accumulated depreciation (1,090,762 ) (1,072,795 ) Total property, plant and equipment, net $ 571,359 $ 577,722 Accrued salary and related expenses consist of: December 28, June 29, (in thousands) Accrued vacation $ 31,223 $ 30,251 Accrued bonus 35,182 71,466 Accrued salaries 8,886 8,329 Accrued fringe benefits 6,397 4,807 Other 13,051 3,851 Total accrued salary and related expenses $ 94,739 $ 118,704

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Dec. 28, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements [Text Block]	FAIR VALUE MEASUREMENTS The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows: Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities. The Company’s Level 1 assets consist of money market funds. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company's Level 3 assets and liabilities consist of acquisition-related contingent consideration liabilities. Assets and liabilities measured at fair value on a recurring basis were as follows: December 28, 2019 June 29, 2019 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Money market funds $ 175,298 $ — $ — $ 175,298 $ 186,819 $ — $ — $ 186,819 Short-term investments Certificates of deposit — — — — — 1,000 — 1,000 Corporate debt securities — 63,006 — 63,006 — 139,990 — 139,990 Other current assets Foreign currency forward contracts — 361 — 361 — 651 — 651 Total assets $ 175,298 $ 63,367 $ — $ 238,665 $ 186,819 $ 141,641 $ — $ 328,460 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 186 $ — $ 186 $ — $ 148 $ — $ 148 Contingent consideration — — — — — — 9,052 9,052 Total Liabilities $ — $ 186 $ — $ 186 $ — $ 148 $ 9,052 $ 9,200 During the six months ended December 28, 2019 and the year ended June 29, 2019 , there were no transfers in or out of Level 3 from other levels in the fair value hierarchy. There were no assets or liabilities measured at fair value on a non-recurring basis as of December 28, 2019 and June 29, 2019 other than impairments of long-lived assets. As of December 28, 2019 and June 29, 2019 , the fair value of private company investments amounted to $20.9 million and $20.7 million , respectively. The aggregate amount of unrealized losses recognized from these investments were $3.0 million and $3.6 million , respectively, as of December 28, 2019 and June 29, 2019 . The Company recorded $0.6 million and $(0.8) million of unrealized gains (losses) on private company investments, during the three months ended December 28, 2019 and December 29, 2018 , respectively. The Company recorded $0.6 million and $(0.7) million , of unrealized gains (losses) on private company investments during the six months ended December 28, 2019 and December 29, 2018

Financial Instruments

Financial Instruments	6 Months Ended
	Dec. 28, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: December 28, 2019 June 29, 2019 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ — $ — $ — $ — $ 1,000 $ — $ — $ 1,000 Corporate debt securities 62,929 86 (9 ) 63,006 140,031 68 (109 ) 139,990 Total available-for-sale investments $ 62,929 $ 86 $ (9 ) $ 63,006 $ 141,031 $ 68 $ (109 ) $ 140,990 In the three and six months ended December 28, 2019 and December 29, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between January 15, 2020 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of December 28, 2019 and June 29, 2019 , the notional amounts of the forward contracts the Company held to purchase international currencies were $41.4 million and $48.5 million , respectively. As of December 28, 2019 and June 29, 2019 , the Company did not hold any forward contracts to sell international currencies. Derivatives not designated as hedging instruments As of December 28, 2019 and June 29, 2019 , the notional amounts of the forward contracts the Company held to purchase international currencies were $50.3 million and $19.6 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $20.7 million and $21.1 million , respectively. The increase in forward contracts held to purchase international currencies from fiscal year 2019 to fiscal year 2020 was primarily due to the addition of operating lease liabilities, which were recorded on the Company’s Consolidated Balance Sheet upon adoption of the new lease accounting standard, Topic 842. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and six months ended December 28, 2019 and December 29, 2018 , respectively. Effect of hedge accounting on the Condensed Consolidated Statements of Income The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Three Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 551,070 $ 190,546 $ 191,468 $ 576,906 $ 203,858 $ 190,844 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 10 $ (404 ) $ 5 $ (82 ) $ (602 ) Six Months Ended Six Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 1,084,110 $ 380,263 $ 378,787 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 130 $ (774 ) $ 44 $ (596 ) $ (1,827 ) Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: December 28, 2019 June 29, 2019 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,000,000 Less: Reduction for unamortized discount and debt issuance costs (6,697 ) (7,416 ) Total long-term debt $ 993,303 $ 992,584 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $11.2 million during the three months ended December 28, 2019 and December 29, 2018 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $17.8 million and $23.6 million , respectively, during the six months ended December 28, 2019 and December 29, 2018 . The estimated fair value of the Company’s outstanding debt obligations was approximately $1.03 billion as of December 28, 2019 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $9.3 million and $11.7 million during the three months ended December 28, 2019 , and December 29, 2018 , respectively. The Company recorded interest expense of $18.6 million and $24.6 million during the six months ended December 28, 2019 , and December 29, 2018 , respectively. Other Financial Instruments

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Dec. 28, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation [Text Block]	STOCK-BASED COMPENSATION At December 28, 2019 , the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants. Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service. RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 28, 2019 and December 29, 2018 , respectively: Three Months Ended Three Months Ended December 28, 2019 December 29, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 5 $ 2,269 $ 699 $ 2,973 $ 9 $ 1,884 $ 495 $ 2,388 Research and development 4 9,918 1,514 11,436 11 8,693 1,135 9,839 Selling, general and administrative 55 8,753 849 9,657 58 8,773 598 9,429 Pre-tax stock-based compensation expense $ 64 $ 20,940 $ 3,062 $ 24,066 $ 78 $ 19,350 $ 2,228 $ 21,656 Less: income tax effect 2,193 2,304 Net stock-based compensation expense $ 21,873 $ 19,352 Six Months Ended Six Months Ended December 28, 2019 December 29, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 14 $ 4,549 $ 1,368 $ 5,931 $ 19 $ 3,646 $ 1,002 $ 4,667 Research and development 8 19,403 2,909 22,320 22 17,384 2,290 19,696 Selling, general and administrative 122 18,706 1,659 20,487 114 16,417 1,259 17,790 Pre-tax stock-based compensation expense $ 144 $ 42,658 $ 5,936 $ 48,738 $ 155 $ 37,447 $ 4,551 $ 42,153 Less: income tax effect 5,081 4,268 Net stock-based compensation expense $ 43,657 $ 37,885 The expense included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $2.4 million and $2.9 million for the three months ended December 28, 2019 and December 29, 2018 , respectively, and $6.8 million and $5.3 million for the six months ended December 28, 2019 and December 29, 2018 , respectively. Stock Options The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model. There were no stock options granted in the three and six months ended December 28, 2019 and December 29, 2018 . The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 28, 2019 and related activity for the six months ended December 28, 2019 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 29, 2019 777,413 $ 28.30 Options Granted — — Options Exercised (302,708 ) 27.82 Options Cancelled (16,575 ) 27.30 Balance at December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 Exercisable, December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 Vested and expected to vest, December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 28, 2019. As of December 28, 2019 , there was no unrecognized stock compensation from unvested stock options. Restricted Stock Units and Other Awards The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. The weighted-average fair value of RSUs and other awards granted was $56.21 and $50.90 per share for the three months ended December 28, 2019 and December 29, 2018 , respectively, and $48.30 and $54.71 per share for the six months ended December 28, 2019 and December 29, 2018 , respectively. The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 28, 2019 and related activity during the six months ended December 28, 2019 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 29, 2019 4,918,306 Restricted stock units and other awards granted 1,550,765 Restricted stock units and other awards released (795,156 ) Restricted stock units and other awards cancelled (269,743 ) Balance at December 28, 2019 5,404,172 2.8 $ 332,572,745 Outstanding and expected to vest, December 28, 2019 4,513,314 2.8 $ 277,749,319 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 28, 2019. The Company withheld shares totaling $7.6 million and $17.6 million in value as a result of employee withholding taxes based on the value of RSUs on their vesting date for the three and six months ended December 28, 2019 . Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows. As of December 28, 2019 , there was $175.2 million of unrecognized compensation expense related to 5.4 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.8 years . Market Stock Units (MSUs) The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The weighted-average fair value of MSUs granted was $54.70 and $75.48 per share for the six months ended December 28, 2019 and December 29, 2018 , respectively. The following table summarizes the number of MSUs outstanding and expected to vest as of December 28, 2019 and their activity during the six months ended December 28, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 29, 2019 1,048,532 Market stock units granted 259,984 Market stock units released (183,974 ) Market stock units cancelled (140,290 ) Balance at December 28, 2019 984,252 2.8 $ 60,570,868 Outstanding and expected to vest, December 28, 2019 350,417 2.7 $ 21,564,655 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 28, 2019. As of December 28, 2019 , there was $32.4 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.8 years . Employee Stock Purchase Plan Employees are granted rights to acquire common stock under the 2008 ESPP. The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Six Months Ended December 28, 2019 December 29, 2018 December 28, 2019 December 29, 2018 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 1.6% - 2.7% 1.6% - 2.6% 1.6% - 2.7% 1.6% - 2.6% Expected stock price volatility 28.4% - 31.3% 19.6% - 32.7% 28.4% - 31.3% 19.6% - 32.7% Dividend yield 3.1% - 3.4% 2.1% - 3.1% 3.1% - 3.4% 2.1% - 3.1% As of December 28, 2019 and December 29, 2018 , there was $10.1 million and $8.6 million , respectively, of unrecognized compensation expense related to the 2008 ESPP.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Dec. 28, 2019
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Six Months Ended December 28, 2019 December 29, 2018 December 28, December 29, (in thousands, except per share data) Numerator for basic earnings per share and diluted earnings per share Net income $ 146,050 $ 131,892 $ 286,206 $ 329,315 Denominator for basic earnings per share 270,330 276,252 270,859 277,144 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 2,939 3,756 3,025 4,270 Denominator for diluted earnings per share 273,269 280,008 273,884 281,414 Earnings per share Basic $ 0.54 $ 0.48 $ 1.06 $ 1.19 Diluted $ 0.53 $ 0.47 $ 1.04 $ 1.17 For the three and six months ended December 28, 2019 and December 29, 2018

Segment Information

Segment Information	6 Months Ended
	Dec. 28, 2019
Segment Reporting [Abstract]
Segment Information [Text Block]	SEGMENT INFORMATION The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors. one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280” ) , the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year. Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Six Months Ended December 28, December 29, December 28, December 29, (in thousands) United States $ 58,909 $ 64,845 $ 114,707 $ 136,974 China 217,099 208,717 414,398 428,015 Rest of Asia 163,563 186,840 333,478 407,221 Europe 98,254 100,662 194,194 212,030 Rest of World 13,245 15,842 27,333 31,161 $ 551,070 $ 576,906 $ 1,084,110 $ 1,215,401 Net long-lived assets by geographic region were as follows: December 28, June 29, (in thousands) United States $ 375,860 $ 379,308 Philippines 97,784 102,634 Rest of World 97,715 95,780 $ 571,359 $ 577,722

Comprehensive Income Loss

Comprehensive Income Loss	6 Months Ended
	Dec. 28, 2019
Statement of Comprehensive Income [Abstract]
Comprehensive Income [Text Block]	COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the six months ended December 28, 2019 and December 29, 2018 were as follows: (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 29, 2019 $ (6,280 ) $ (4,322 ) $ (1,136 ) $ 425 $ (41 ) $ (11,354 ) Other comprehensive income (loss) before reclassifications — — — (941 ) 135 (806 ) Amounts reclassified out of accumulated other comprehensive (income) loss — 238 — 644 — 882 Tax effects — (42 ) — 48 (17 ) (11 ) Other comprehensive income (loss), net — 196 — (249 ) 118 65 December 28, 2019 $ (6,280 ) $ (4,126 ) $ (1,136 ) $ 176 $ 77 $ (11,289 ) (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (551 ) 2,205 1,654 Amounts reclassified out of accumulated other comprehensive (income) loss — 191 — 2,379 — 2,570 Tax effects — (37 ) — (310 ) (228 ) (575 ) Other comprehensive income (loss), net — 154 — 1,518 1,977 3,649 December 29, 2018 $ (6,280 ) $ (2,362 ) $ (1,136 ) $ 135 $ (1,693 ) $ (11,336 )

Income Taxes

Income Taxes	6 Months Ended
	Dec. 28, 2019
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and six months ended December 28, 2019 the Company recorded an income tax provision of $23.0 million and $40.7 million , respectively, compared to $50.8 million and $87.0 million for the three and six months ended December 29, 2018 , respectively. The Company’s effective tax rate for the three and six months ended December 28, 2019 was 13.6% and 12.4% , respectively, compared to 27.8% and 20.9% for the three and six months ended December 29, 2018 , respectively. On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of the Company's foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered additional information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019, the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the three and six months ended December 29, 2018 by 12.1% and 5.3% , respectively. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act was completed. The Company’s federal statutory tax rate is 21% . The Company’s effective tax rate for the three and six months ended December 28, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by U.S. tax expense related to Global Intangible Low-Taxed Income (“GILTI”). The Company’s effective tax rate for the three months ended December 29, 2018 was higher than the statutory rate primarily due to a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $4.9 million discrete charge for interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates. The Company’s effective tax rate for the six months ended December 29, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $9.4 million discrete charge for interest accruals for unrecognized tax benefits. The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that the balance of gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $56.0 million within the next twelve months due to the completion of federal tax audits, including any administrative appeals. The $56.0 million primarily relates to matters involving federal taxation of cross-border transactions. The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In fiscal year 2020 the IRS commenced an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2017, which is ongoing.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 28, 2019
Product Warranties Disclosures [Abstract]
Commitments and Contingencies [Text Block]	COMMITMENTS AND CONTINGENCIES Legal Proceedings The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any. Indemnification The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims. Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

Common Stock Repurchases

Common Stock Repurchases	6 Months Ended
	Dec. 28, 2019
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	COMMON STOCK REPURCHASES On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $ 1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generated from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization. During the six months ended December 28, 2019 , the Company repurchased approximately 3.5 million shares of its common stock for $201.5 million . As of December 28, 2019 , the Company had remaining authorization of $0.9 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

Acquisitions (Notes)

Acquisitions (Notes)	6 Months Ended
	Dec. 28, 2019
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	LEASES The Company's lease obligations consist of operating leases for domestic and international office facilities, data centers, and equipment. These leases expire at various dates through fiscal year 2031. For the three and six months ended December 28, 2019 , the Company recorded operating lease expense of $2.9 million and $5.9 million , respectively. Leases are included in the following Condensed Consolidated Balance Sheet lines: December 28, 2019 (in thousands) Other assets $ 56,170 Accrued expenses $ 10,028 Other liabilities $ 50,784 Future minimum lease payments under non-cancelable operating leases as of December 28, 2019 are as follows: Operating Lease Obligations Fiscal Year (in thousands) Remainder of 2020 $ 5,969 2021 11,818 2022 10,847 2023 9,599 2024 8,202 Thereafter 21,904 Total 68,339 Less imputed interest 7,657 Total $ 60,682 Other information related to leases as of December 28, 2019 are as follows: Six Months Ended December 28, 2019 Supplemental cash flow information (in thousands) Operating cash flows used for operating leases $ 5,911 Weighted-average remaining lease term - operating leases, in years 7 Weighted-average discount rate - operating leases 3.45 %

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 28, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill during the six months ended December 28, 2019 . No indicators or instances of impairment were identified during the six months and fiscal year ended December 28, 2019 and June 29, 2019 , respectively. Intangible Assets Intangible assets consisted of the following: December 28, 2019 June 29, 2019 Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 490,136 $ 451,780 $ 38,356 $ 487,346 $ 445,558 $ 41,788 Customer relationships 116,505 107,244 9,261 116,505 105,901 10,604 Trade name 9,974 9,082 892 9,974 8,914 1,060 Patents 2,500 2,500 — 2,500 2,500 — Total amortizable purchased intangible assets 619,115 570,606 48,509 616,325 562,873 53,452 In-process research & development (IPR&D) — — — 2,790 — 2,790 Total purchased intangible assets $ 619,115 $ 570,606 $ 48,509 $ 619,115 $ 562,873 $ 56,242 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 28, December 29, December 28, December 29, (in thousands) Cost of goods sold $ 3,111 $ 6,868 $ 6,221 $ 13,783 Intangible asset amortization 756 756 1,512 1,529 Total intangible asset amortization expenses $ 3,867 $ 7,624 $ 7,733 $ 15,312 The following table represents the estimated future amortization expense of intangible assets as of December 28, 2019 : Amount Fiscal Year (in thousands) Remainder of 2020 $ 7,733 2021 13,767 2022 8,088 2023 7,604 2024 4,628 Thereafter 6,689 Total intangible assets $ 48,509

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Dec. 28, 2019
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories consist of: December 28, June 29, (in thousands) Raw materials $ 13,222 $ 16,121 Work-in-process 142,551 160,273 Finished goods 68,185 70,118 Total inventories $ 223,958 $ 246,512
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net, consist of: December 28, June 29, (in thousands) Land $ 17,720 $ 17,720 Buildings and building improvements 306,052 265,191 Machinery, equipment and software 1,338,349 1,367,606 Total 1,662,121 1,650,517 Less: accumulated depreciation (1,090,762 ) (1,072,795 ) Total property, plant and equipment, net $ 571,359 $ 577,722
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accrued salary and related expenses consist of: December 28, June 29, (in thousands) Accrued vacation $ 31,223 $ 30,251 Accrued bonus 35,182 71,466 Accrued salaries 8,886 8,329 Accrued fringe benefits 6,397 4,807 Other 13,051 3,851 Total accrued salary and related expenses $ 94,739 $ 118,704

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Dec. 28, 2019
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured at fair value on a recurring basis were as follows: December 28, 2019 June 29, 2019 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Money market funds $ 175,298 $ — $ — $ 175,298 $ 186,819 $ — $ — $ 186,819 Short-term investments Certificates of deposit — — — — — 1,000 — 1,000 Corporate debt securities — 63,006 — 63,006 — 139,990 — 139,990 Other current assets Foreign currency forward contracts — 361 — 361 — 651 — 651 Total assets $ 175,298 $ 63,367 $ — $ 238,665 $ 186,819 $ 141,641 $ — $ 328,460 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 186 $ — $ 186 $ — $ 148 $ — $ 148 Contingent consideration — — — — — — 9,052 9,052 Total Liabilities $ — $ 186 $ — $ 186 $ — $ 148 $ 9,052 $ 9,200

Financial Instruments (Tables)

Financial Instruments (Tables)	6 Months Ended
	Dec. 28, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments, Gain (Loss) [Table Text Block]	The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Three Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 551,070 $ 190,546 $ 191,468 $ 576,906 $ 203,858 $ 190,844 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 10 $ (404 ) $ 5 $ (82 ) $ (602 ) Six Months Ended Six Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 1,084,110 $ 380,263 $ 378,787 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 130 $ (774 ) $ 44 $ (596 ) $ (1,827 )
Available-for-sale investments [Table Text Block]	Fair values were as follows: December 28, 2019 June 29, 2019 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ — $ — $ — $ — $ 1,000 $ — $ — $ 1,000 Corporate debt securities 62,929 86 (9 ) 63,006 140,031 68 (109 ) 139,990 Total available-for-sale investments $ 62,929 $ 86 $ (9 ) $ 63,006 $ 141,031 $ 68 $ (109 ) $ 140,990
Schedule of long-term debt [Table Text Block]	The following table summarizes the Company’s outstanding debt obligations: December 28, 2019 June 29, 2019 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,000,000 Less: Reduction for unamortized discount and debt issuance costs (6,697 ) (7,416 ) Total long-term debt $ 993,303 $ 992,584
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: December 28, 2019 June 29, 2019 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ — $ — $ — $ — $ 1,000 $ — $ — $ 1,000 Corporate debt securities 62,929 86 (9 ) 63,006 140,031 68 (109 ) 139,990 Total available-for-sale investments $ 62,929 $ 86 $ (9 ) $ 63,006 $ 141,031 $ 68 $ (109 ) $ 140,990 In the three and six months ended December 28, 2019 and December 29, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between January 15, 2020 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of December 28, 2019 and June 29, 2019 , the notional amounts of the forward contracts the Company held to purchase international currencies were $41.4 million and $48.5 million , respectively. As of December 28, 2019 and June 29, 2019 , the Company did not hold any forward contracts to sell international currencies. Derivatives not designated as hedging instruments As of December 28, 2019 and June 29, 2019 , the notional amounts of the forward contracts the Company held to purchase international currencies were $50.3 million and $19.6 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $20.7 million and $21.1 million , respectively. The increase in forward contracts held to purchase international currencies from fiscal year 2019 to fiscal year 2020 was primarily due to the addition of operating lease liabilities, which were recorded on the Company’s Consolidated Balance Sheet upon adoption of the new lease accounting standard, Topic 842. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and six months ended December 28, 2019 and December 29, 2018 , respectively. Effect of hedge accounting on the Condensed Consolidated Statements of Income The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Three Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 551,070 $ 190,546 $ 191,468 $ 576,906 $ 203,858 $ 190,844 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 10 $ (404 ) $ 5 $ (82 ) $ (602 ) Six Months Ended Six Months Ended December 28, 2019 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 1,084,110 $ 380,263 $ 378,787 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ — $ 130 $ (774 ) $ 44 $ (596 ) $ (1,827 ) Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: December 28, 2019 June 29, 2019 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,000,000 Less: Reduction for unamortized discount and debt issuance costs (6,697 ) (7,416 ) Total long-term debt $ 993,303 $ 992,584 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $11.2 million during the three months ended December 28, 2019 and December 29, 2018 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $17.8 million and $23.6 million , respectively, during the six months ended December 28, 2019 and December 29, 2018 . The estimated fair value of the Company’s outstanding debt obligations was approximately $1.03 billion as of December 28, 2019 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $9.3 million and $11.7 million during the three months ended December 28, 2019 , and December 29, 2018 , respectively. The Company recorded interest expense of $18.6 million and $24.6 million during the six months ended December 28, 2019 , and December 29, 2018 , respectively. Other Financial Instruments

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Dec. 28, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 28, 2019 and December 29, 2018 , respectively: Three Months Ended Three Months Ended December 28, 2019 December 29, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 5 $ 2,269 $ 699 $ 2,973 $ 9 $ 1,884 $ 495 $ 2,388 Research and development 4 9,918 1,514 11,436 11 8,693 1,135 9,839 Selling, general and administrative 55 8,753 849 9,657 58 8,773 598 9,429 Pre-tax stock-based compensation expense $ 64 $ 20,940 $ 3,062 $ 24,066 $ 78 $ 19,350 $ 2,228 $ 21,656 Less: income tax effect 2,193 2,304 Net stock-based compensation expense $ 21,873 $ 19,352 Six Months Ended Six Months Ended December 28, 2019 December 29, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 14 $ 4,549 $ 1,368 $ 5,931 $ 19 $ 3,646 $ 1,002 $ 4,667 Research and development 8 19,403 2,909 22,320 22 17,384 2,290 19,696 Selling, general and administrative 122 18,706 1,659 20,487 114 16,417 1,259 17,790 Pre-tax stock-based compensation expense $ 144 $ 42,658 $ 5,936 $ 48,738 $ 155 $ 37,447 $ 4,551 $ 42,153 Less: income tax effect 5,081 4,268 Net stock-based compensation expense $ 43,657 $ 37,885
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 28, 2019 and related activity for the six months ended December 28, 2019 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 29, 2019 777,413 $ 28.30 Options Granted — — Options Exercised (302,708 ) 27.82 Options Cancelled (16,575 ) 27.30 Balance at December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 Exercisable, December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 Vested and expected to vest, December 28, 2019 458,130 $ 28.49 1.0 $ 15,139,460 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 28, 2019.
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 28, 2019 and related activity during the six months ended December 28, 2019 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 29, 2019 4,918,306 Restricted stock units and other awards granted 1,550,765 Restricted stock units and other awards released (795,156 ) Restricted stock units and other awards cancelled (269,743 ) Balance at December 28, 2019 5,404,172 2.8 $ 332,572,745 Outstanding and expected to vest, December 28, 2019 4,513,314 2.8 $ 277,749,319 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 28, 2019.
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the number of MSUs outstanding and expected to vest as of December 28, 2019 and their activity during the six months ended December 28, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 29, 2019 1,048,532 Market stock units granted 259,984 Market stock units released (183,974 ) Market stock units cancelled (140,290 ) Balance at December 28, 2019 984,252 2.8 $ 60,570,868 Outstanding and expected to vest, December 28, 2019 350,417 2.7 $ 21,564,655 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 28, 2019.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Six Months Ended December 28, 2019 December 29, 2018 December 28, 2019 December 29, 2018 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 1.6% - 2.7% 1.6% - 2.6% 1.6% - 2.7% 1.6% - 2.6% Expected stock price volatility 28.4% - 31.3% 19.6% - 32.7% 28.4% - 31.3% 19.6% - 32.7% Dividend yield 3.1% - 3.4% 2.1% - 3.1% 3.1% - 3.4% 2.1% - 3.1%

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Dec. 28, 2019
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Six Months Ended December 28, 2019 December 29, 2018 December 28, December 29, (in thousands, except per share data) Numerator for basic earnings per share and diluted earnings per share Net income $ 146,050 $ 131,892 $ 286,206 $ 329,315 Denominator for basic earnings per share 270,330 276,252 270,859 277,144 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 2,939 3,756 3,025 4,270 Denominator for diluted earnings per share 273,269 280,008 273,884 281,414 Earnings per share Basic $ 0.54 $ 0.48 $ 1.06 $ 1.19 Diluted $ 0.53 $ 0.47 $ 1.04 $ 1.17

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Dec. 28, 2019
Segment Reporting [Abstract]
Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]	Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Six Months Ended December 28, December 29, December 28, December 29, (in thousands) United States $ 58,909 $ 64,845 $ 114,707 $ 136,974 China 217,099 208,717 414,398 428,015 Rest of Asia 163,563 186,840 333,478 407,221 Europe 98,254 100,662 194,194 212,030 Rest of World 13,245 15,842 27,333 31,161 $ 551,070 $ 576,906 $ 1,084,110 $ 1,215,401
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]	Net long-lived assets by geographic region were as follows: December 28, June 29, (in thousands) United States $ 375,860 $ 379,308 Philippines 97,784 102,634 Rest of World 97,715 95,780 $ 571,359 $ 577,722

Comprehensive Income Loss (Tabl

Comprehensive Income Loss (Tables)	6 Months Ended
	Dec. 28, 2019
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the six months ended December 28, 2019 and December 29, 2018 were as follows: (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 29, 2019 $ (6,280 ) $ (4,322 ) $ (1,136 ) $ 425 $ (41 ) $ (11,354 ) Other comprehensive income (loss) before reclassifications — — — (941 ) 135 (806 ) Amounts reclassified out of accumulated other comprehensive (income) loss — 238 — 644 — 882 Tax effects — (42 ) — 48 (17 ) (11 ) Other comprehensive income (loss), net — 196 — (249 ) 118 65 December 28, 2019 $ (6,280 ) $ (4,126 ) $ (1,136 ) $ 176 $ 77 $ (11,289 ) (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (551 ) 2,205 1,654 Amounts reclassified out of accumulated other comprehensive (income) loss — 191 — 2,379 — 2,570 Tax effects — (37 ) — (310 ) (228 ) (575 ) Other comprehensive income (loss), net — 154 — 1,518 1,977 3,649 December 29, 2018 $ (6,280 ) $ (2,362 ) $ (1,136 ) $ 135 $ (1,693 ) $ (11,336 )

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018
Goodwill [Line Items]
Goodwill and Intangible Assets Disclosure [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill during the six months ended December 28, 2019 . No indicators or instances of impairment were identified during the six months and fiscal year ended December 28, 2019 and June 29, 2019 , respectively. Intangible Assets Intangible assets consisted of the following: December 28, 2019 June 29, 2019 Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 490,136 $ 451,780 $ 38,356 $ 487,346 $ 445,558 $ 41,788 Customer relationships 116,505 107,244 9,261 116,505 105,901 10,604 Trade name 9,974 9,082 892 9,974 8,914 1,060 Patents 2,500 2,500 — 2,500 2,500 — Total amortizable purchased intangible assets 619,115 570,606 48,509 616,325 562,873 53,452 In-process research & development (IPR&D) — — — 2,790 — 2,790 Total purchased intangible assets $ 619,115 $ 570,606 $ 48,509 $ 619,115 $ 562,873 $ 56,242 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 28, December 29, December 28, December 29, (in thousands) Cost of goods sold $ 3,111 $ 6,868 $ 6,221 $ 13,783 Intangible asset amortization 756 756 1,512 1,529 Total intangible asset amortization expenses $ 3,867 $ 7,624 $ 7,733 $ 15,312 The following table represents the estimated future amortization expense of intangible assets as of December 28, 2019 : Amount Fiscal Year (in thousands) Remainder of 2020 $ 7,733 2021 13,767 2022 8,088 2023 7,604 2024 4,628 Thereafter 6,689 Total intangible assets $ 48,509
Schedule of intangible assets [Table Text Block]	Intangible assets consisted of the following: December 28, 2019 June 29, 2019 Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 490,136 $ 451,780 $ 38,356 $ 487,346 $ 445,558 $ 41,788 Customer relationships 116,505 107,244 9,261 116,505 105,901 10,604 Trade name 9,974 9,082 892 9,974 8,914 1,060 Patents 2,500 2,500 — 2,500 2,500 — Total amortizable purchased intangible assets 619,115 570,606 48,509 616,325 562,873 53,452 In-process research & development (IPR&D) — — — 2,790 — 2,790 Total purchased intangible assets $ 619,115 $ 570,606 $ 48,509 $ 619,115 $ 562,873 $ 56,242
Schedule of amortization expense allocation of intangible assets [Table Text Block]		The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 28, December 29, December 28, December 29, (in thousands) Cost of goods sold $ 3,111 $ 6,868 $ 6,221 $ 13,783 Intangible asset amortization 756 756 1,512 1,529 Total intangible asset amortization expenses $ 3,867 $ 7,624 $ 7,733 $ 15,312
Estimated future amortization expense of intangible assets [Table Text Block]	The following table represents the estimated future amortization expense of intangible assets as of December 28, 2019 : Amount Fiscal Year (in thousands) Remainder of 2020 $ 7,733 2021 13,767 2022 8,088 2023 7,604 2024 4,628 Thereafter 6,689 Total intangible assets $ 48,509

Leases (Tables)

Leases (Tables)	6 Months Ended
	Dec. 28, 2019
Balance Sheet Items Related to Leases [Abstract]
Balance sheet items related to leases [Table Text Block]	December 28, 2019 (in thousands) Other assets $ 56,170 Accrued expenses $ 10,028 Other liabilities $ 50,784
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Operating Lease Obligations Fiscal Year (in thousands) Remainder of 2020 $ 5,969 2021 11,818 2022 10,847 2023 9,599 2024 8,202 Thereafter 21,904 Total 68,339 Less imputed interest 7,657 Total $ 60,682

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019
New Accounting Pronouncement, Early Adoption [Line Items]
Accounts Receivable, Net, Current	$ 348,342		$ 360,016
Cash flow from operating activities operating activities	378,735	$ 431,435
Price adjustment and other revenue reserves	$ 105,237		$ 100,490

Recently Issued Accounting Pr_3

Recently Issued Accounting Pronouncements Adjustments for New Accounting Pronouncements (Details) - USD ($) $ in Thousands	Dec. 28, 2019	Jun. 30, 2019
Accounting Changes and Error Corrections [Abstract]
Operating Lease, Right-of-Use Asset	$ 56,170	$ 61,000
Operating Lease, Liability	$ 60,682	65,200
Deferred Rent Credit, Noncurrent		$ 4,200

Balance Sheet Components (Detai

Balance Sheet Components (Details) - USD ($) $ in Thousands	Dec. 28, 2019	Jun. 29, 2019
Inventories:
Raw materials	$ 13,222	$ 16,121
Work-in-process	142,551	160,273
Finished goods	68,185	70,118
Inventory, net	223,958	246,512
Property, plant and equipment:
Land	17,720	17,720
Buildings and building improvements	306,052	265,191
Machinery and equipment	1,338,349	1,367,606
Property, plant and equipment, gross	1,662,121	1,650,517
Less: accumulated depreciation and amortization	(1,090,762)	(1,072,795)
Property, plant and equipment, net	571,359	577,722
Employee-related Liabilities, Current [Abstract]
Accrued Vacation	31,223	30,251
Accrued Bonuses	35,182	71,466
Accrued Salaries	8,886	8,329
Accrued Employee Benefits	6,397	4,807
Other	13,051	3,851
Accrued salary and related expenses	$ 94,739	$ 118,704

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019	Jun. 30, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of long-lived assets	$ 0	$ 753	$ 0	$ 753
Interest Expense, Debt	8,900	11,200	17,800	23,600
Cash and cash equivalents	1,720,194	$ 1,406,740	1,720,194	$ 1,406,740	$ 1,757,342	$ 1,543,484
Available-for-sale Securities					140,990
Business Combination, Contingent Consideration, Liability					9,052
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	238,665		238,665		328,460
Total Liabilities	186		186		9,200
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	175,298		175,298		186,819
Total Liabilities	0		0		0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	63,367		63,367		141,641
Total Liabilities	186		186		148
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	0		0		0
Total Liabilities	0		0		9,052
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	175,298		175,298		186,819
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	175,298		175,298		186,819
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Corporate debt securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	63,006		63,006		139,990
Corporate debt securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	63,006		63,006		139,990
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	361		361		651
Foreign currency forward contracts	186		186		148
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	361		361		651
Foreign currency forward contracts	186		186		148
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	0		0		9,052
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	0		0
Certificates of deposit | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0		0		1,000
Certificates of deposit | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 0		$ 0		$ 1,000

Fair Value Measurements Private

Fair Value Measurements Private Company Investments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019
Investments, Debt and Equity Securities [Abstract]
Cost Method Investments	$ 20.9		$ 20.9		$ 20.7
Accumulated gains or losses on private company investments	3		3		$ 3.6
Unrealized Gain (Loss) on Securities	$ 0.6	$ (0.8)	$ 0.6	$ (0.7)

Financial Instruments, Short-te

Financial Instruments, Short-term Investments (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Jun. 29, 2019
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Dec. 28, 2019
Debt Securities, Available-for-sale [Abstract]
Estimated Fair Value		$ 140,990
Debt Securities, Available-for-sale, Amortized Cost	$ 62,929	141,031
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	86	68
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	9	109
Debt Securities, Available-for-sale	63,006
Certificates of deposit
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	0	1,000
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-sale	0	1,000
Corporate debt securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	62,929	140,031
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	86	68
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	9	109
Debt Securities, Available-for-sale	$ 63,006	$ 139,990

Financial Instruments Financial

Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019	Mar. 30, 2013
Investment [Line Items]
Document Period End Date	Dec. 28, 2019
Proceeds from sale of shares	$ 0	$ 27,253
Estimated Fair Value			$ 140,990
Not Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member]
Investment [Line Items]
Derivative Asset, Notional Amount	50,300		19,600
Not Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member]
Investment [Line Items]
Derivative Asset, Notional Amount	20,700		21,100
Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative Asset, Notional Amount	$ 41,400		48,500
Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Investment [Line Items]
proceeds from issuance of long term debt 3			$ 494,500	$ 490,000

Financial Instruments, Long-ter

Financial Instruments, Long-term Debt (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Jun. 24, 2017	Jun. 29, 2019	Mar. 30, 2013
Debt Instrument [Line Items]
Document Period End Date			Dec. 28, 2019
Debt, Long-term and Short-term, Combined Amount	$ 1,000,000		$ 1,000,000			$ 1,000,000
Less: Reduction for unamortized discount and debt issuance costs	(6,697)			$ (7,416)
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed					101.00%
Interest expense relating to the Notes	8,900	$ 11,200	17,800	23,600
Estimated fair value of long-term debt	1,030,000		1,030,000
Interest Expense	9,300	$ 11,700	18,600	$ 24,600
Secured Long-term Debt, Noncurrent	993,303		993,303			992,584
Fixed Rate Note Due June 2027 at 3 Point 45 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000		$ 500,000		$ 500,000	500,000
Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]
Debt Instrument [Line Items]
Long-term debt						$ 500,000
Stated interest rate of the notes	0.00%		0.00%			2.50%
Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000		$ 500,000			$ 500,000	$ 500,000
Effective interest rate of the Notes							3.50%
proceeds from issuance of long term debt 3						$ 494,500	$ 490,000
FixedRateNoteDueJune2027at3Point450Percent[Member] [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.45%		3.45%		3.45%	3.45%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Domain]
Debt Instrument [Line Items]
Effective interest rate of the Notes					3.50%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Member]
Debt Instrument [Line Items]
Net Proceeds From Issuance of Long Term Debt 5					$ 495,200
Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.375%		3.375%			3.375%	3.375%

Financial Instruments Gain (Los

Financial Instruments Gain (Loss) from Hedging Activities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Derivative [Line Items]
Document Period End Date			Dec. 28, 2019
Revenue from Contract with Customer, Excluding Assessed Tax	$ 551,070	$ 576,906	$ 1,084,110	$ 1,215,401
Cost of goods sold	190,546	203,858	380,263	412,117
Revenues	551,070	576,906	1,084,110	1,215,401
Operating Expenses	191,468	190,844	378,787	386,898
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			(882)	(2,570)
Accumulated Net Gain (Loss) from Cost of Good Solds Attributable to Parent [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	10	(82)	130	(596)
Accumulated Net Gain (Loss) from Operating Expense Attributable to Parent [Member] [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(404)	(602)	(774)	(1,827)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 0	$ 5	$ 0	$ 44

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Document Period End Date			Dec. 28, 2019
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 24,066	$ 21,656	$ 48,738	$ 42,153
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,193	2,304	5,081	4,268
Net stock-based compensation expense	21,873	19,352	43,657	37,885
Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,973	2,388	5,931	4,667
Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	11,436	9,839	22,320	19,696
General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,657	9,429	20,487	17,790
Stock options [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	64	78	144	155
Stock options [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	5	9	14	19
Stock options [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	4	11	8	22
Stock options [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	55	58	122	114
Restricted Stock Units (RSUs) [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	20,940	19,350	42,658	37,447
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,269	1,884	4,549	3,646
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,918	8,693	19,403	17,384
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8,753	8,773	18,706	16,417
ESP Plan [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	3,062	2,228	5,936	4,551
ESP Plan [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	699	495	1,368	1,002
ESP Plan [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,514	1,135	2,909	2,290
ESP Plan [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	849	598	1,659	1,259
Market stock units [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 2,400	$ 2,900	$ 6,800	$ 5,300

Stock-Based Compensation, Stock

Stock-Based Compensation, Stock Option Plans (Details)	6 Months Ended
	Dec. 28, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Unrecognized compensation costs related to unvested units | $	$ 175,200,000
Weighted average period of recognition for unrecognized compensation costs (in years)	2 years 9 months 18 days
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning | shares	777,413,000
Options Granted | shares	0
Options Exercised | shares	(302,708,000)
Options Cancelled | shares	(16,575,000)
Options outstanding, ending | shares	458,130,000
Options exercisable, number of shares | shares	458,130,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, weighted average exercise price, beginning (per share)	$ 28.30
Options granted, weighted average exercise price (per share)	0
Options exercised, weighted average exercise price (per share)	27,820
Options cancelled, weighted average exercise price (per share)	27,300
Options outstanding, weighted average exercise price, ending (per share)	28,490
Options exercisable, weighted average exercise price (per share)	28,490
Options vested and expected to vest, weighted average exercise price (per share)	$ 28,490
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term (in years)	1 year
Options exercisable, weighted average remaining contractual term (in years)	1 year
Options vested and expected to vest, weighted average remaining contractual term (in years)	1 year
Options outstanding, aggregate intrinsic value | $	$ 15,139,460
Options exercisable, aggregate intrinsic value | $	15,139,460
Options vested and expected to vest, aggregate intrinsic value | $	15,139,460
Unrecognized compensation costs related to unvested units | $	$ 0

Stock-Based Compensation, Restr

Stock-Based Compensation, Restricted Stock Units (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accrued Employee Stock Purchase Program Withholding	$ 7,600,000		$ 17,600,000
Outstanding and expected to vest RSUs [Roll Forward]
Unrecognized compensation costs related to unvested units	$ 175,200,000		$ 175,200,000
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 9 months 18 days
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (per share)	$ 56.21	$ 50.90	$ 48.30	$ 54.71
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning			4,918,306
Granted			1,550,765
Released			(795,156)
Cancelled			(269,743)
Outstanding, ending	5,404,172		5,404,172
Expected to vest, number of shares	4,513,314		4,513,314
Outstanding, weighted average remaining contractual term (in years)			2 years 9 months 18 days
Restricted stock units vested and expected to vest, weighted average remaining contractual term 1			2 years 9 months 18 days
Outstanding, aggregate intrinsic value	$ 332,572,745		$ 332,572,745
Restricted stock units expected to vest, aggregate intrinsic value	$ 277,749,319		$ 277,749,319
Restricted Stock [Member]
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, ending	5,400		5,400

Stock-Based Compensation Stock

Stock-Based Compensation Stock Based Compensation, Market Stock Units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]			The following table summarizes the number of MSUs outstanding and expected to vest as of December 28, 2019 and their activity during the six months ended December 28, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 29, 2019 1,048,532 Market stock units granted 259,984 Market stock units released (183,974 ) Market stock units cancelled (140,290 ) Balance at December 28, 2019 984,252 2.8 $ 60,570,868 Outstanding and expected to vest, December 28, 2019 350,417 2.7 $ 21,564,655 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 28, 2019.
Allocated Share-based Compensation Expense	$ 24,066	$ 21,656	$ 48,738	$ 42,153
Outstanding and expected to vest MSUs [Roll Forward]
Unrecognized compensation costs related to unvested units	175,200		$ 175,200
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 9 months 18 days
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 2,400	$ 2,900	$ 6,800	$ 5,300
Market Stock Units [Member]
Outstanding and expected to vest MSUs [Roll Forward]
Weighted average grant date fair value (per share)	$ 54.70		$ 75.48
Outstanding, beginning			1,048,532
Granted			259,984
Released			(183,974)
Cancelled			(140,290)
Outstanding, ending	984,252		984,252
Expected to vest, number of shares	350,417		350,417
Outstanding, weighted average remaining contractual term (in years)			2 years 9 months 18 days
Outstanding and expected to Vest, weighted average remaining contractual term 3			2 years 8 months 12 days
Outstanding, aggregate intrinsic value	$ 60,570,868		$ 60,570,868
Outstanding and expected to vest, aggregate intrinsic value	21,564,655		21,564,655
Unrecognized compensation costs related to unvested units	$ 32,400		$ 32,400
Market Stock Units (MSU) [Member] [Domain]
Outstanding and expected to vest MSUs [Roll Forward]
Outstanding, ending	1,000		1,000

Stock-Based Compensation, Emplo

Stock-Based Compensation, Employee Stock Purchase Plan (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date			Dec. 28, 2019
Allocated Share-based Compensation Expense	$ 24,066	$ 21,656	$ 48,738	$ 42,153
Risk-free interest rate	1.60%	1.60%	1.60%	1.60%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.10%	2.10%	3.10%	2.10%
Unrecognized compensation costs related to unvested units	$ 175,200		$ 175,200
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 9 months 18 days
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,193	$ 2,304	$ 5,081	$ 4,268
Allocated Share-based Compensation Expense, Net of Tax	$ 21,873	$ 19,352	$ 43,657	$ 37,885
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	2.70%	2.60%	2.70%	2.60%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	28.40%	19.60%	28.40%	19.60%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	31.30%	32.70%	31.30%	32.70%
Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Dividend Rate, Maximum	3.40%	3.10%	3.40%	3.10%
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 2,400	$ 2,900	$ 6,800	$ 5,300
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	458,130		458,130		777,413
Allocated Share-based Compensation Expense	$ 64	78	$ 144	155
Unrecognized compensation costs related to unvested units	0		0
ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,062	$ 2,228	$ 5,936	$ 4,551
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	15 days	15 days	15 days	15 days
Unrecognized compensation costs related to unvested units	$ 10,100	$ 8,600	$ 10,100	$ 8,600
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	20,940	19,350	42,658	37,447
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,973	2,388	5,931	4,667
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	5	9	14	19
Cost of Sales [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	699	495	1,368	1,002
Cost of Sales [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,269	1,884	4,549	3,646
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	11,436	9,839	22,320	19,696
Research and Development Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	4	11	8	22
Research and Development Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,514	1,135	2,909	2,290
Research and Development Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,918	8,693	19,403	17,384
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,657	9,429	20,487	17,790
General and Administrative Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	55	58	122	114
General and Administrative Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	849	598	1,659	1,259
General and Administrative Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 8,753	$ 8,773	$ 18,706	$ 16,417

Stock-Based Compensation Stoc_2

Stock-Based Compensation Stock based compensation, net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Document Period End Date			Dec. 28, 2019
Allocated Share-based Compensation Expense	$ 24,066	$ 21,656	$ 48,738	$ 42,153
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,193	2,304	5,081	4,268
Allocated Share-based Compensation Expense, Net of Tax	$ 21,873	$ 19,352	$ 43,657	$ 37,885

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 146,050	$ 131,892	$ 286,206	$ 329,315
Denominator for basic earnings per share	270,330,000	276,252,000	270,859,000	277,144,000
Effect of dilutive securities
Stock options, ESPP and RSUs	2,939,000	3,756,000	3,025,000	4,270,000
Denominator for diluted earnings per share	273,269,000	280,008,000	273,884,000	281,414,000
Earnings per share, Basic (per share)	$ 0.54	$ 0.48	$ 1.06	$ 1.19
Earnings per share, Diluted (per share)	$ 0.53	$ 0.47	$ 1.04	$ 1.17
Antidilutive securities excluded from computation of earnings per share	0	0	0	0

Earnings Per Share EPS (Details

Earnings Per Share EPS (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Earnings Per Share [Abstract]
Net income	$ 146,050	$ 131,892	$ 286,206	$ 329,315

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019USD ($)customers	Dec. 29, 2018USD ($)	Dec. 28, 2019USD ($)	Dec. 29, 2018USD ($)	Jun. 29, 2019USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | customers	1
Revenues	$ 551,070	$ 576,906	$ 1,084,110	$ 1,215,401
Long-lived assets	571,359		571,359		$ 577,722
United States [Member]
Segment Reporting Information [Line Items]
Revenues	58,909	64,845	114,707	136,974
Long-lived assets	375,860		375,860		379,308
China [Member]
Segment Reporting Information [Line Items]
Revenues	217,099	208,717	414,398	428,015
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	163,563	186,840	333,478	407,221
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	98,254	100,662	194,194	212,030
Philippines [Member]
Segment Reporting Information [Line Items]
Long-lived assets	97,784		97,784		102,634
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	13,245	$ 15,842	27,333	$ 31,161
Long-lived assets	$ 97,715		$ 97,715		$ 95,780

Comprehensive Income Loss Accum

Comprehensive Income Loss Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			$ (11,354)	$ (14,985)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(806)	1,654
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			882	2,570
Other Comprehensive Income (Loss), Tax			(11)	(575)
Other comprehensive income (loss), net	$ 708	$ 1,384	65	3,649
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,289)	(11,336)	(11,289)	(11,336)
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(6,280)	(6,280)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,280)	(6,280)	(6,280)	(6,280)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(4,322)	(2,516)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			238	191
Other Comprehensive Income (Loss), Tax			(42)	(37)
Other comprehensive income (loss), net			196	154
Accumulated Other Comprehensive Income (Loss), Net of Tax	(4,126)	(2,362)	(4,126)	(2,362)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(1,136)	(1,136)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,136)	(1,136)	(1,136)	(1,136)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			425	(1,383)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(941)	(551)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			644	2,379
Other Comprehensive Income (Loss), Tax			48	(310)
Other comprehensive income (loss), net			(249)	1,518
Accumulated Other Comprehensive Income (Loss), Net of Tax	176	135	176	135
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(41)	(3,670)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			135	2,205
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			(17)	(228)
Other comprehensive income (loss), net			118	1,977
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ 77	$ (1,693)	$ 77	$ (1,693)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Income Tax Disclosure [Abstract]
Deferred Tax Assets, State Taxes		$ 4,900		$ 9,400
Unrecognized Tax Benefits, Period Increase (Decrease)			$ 56,000
Income tax provision	$ 22,989	$ 50,784	$ 40,666	$ 86,997
Effective Income Tax Rate Reconciliation, Percent	13.60%	27.80%	12.40%	20.90%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount				$ 236,900

Income Taxes Income Tax Disclos

Income Taxes Income Tax Disclosure (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$ 22,989	$ 50,784	$ 40,666	$ 86,997
Effective Income Tax Rate Reconciliation, Percent	13.60%	27.80%	12.40%	20.90%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount				$ 236,900
Tax Adjustments, Settlements, and Unusual Provisions		$ 22,100
Deferred Tax Assets, State Taxes		$ 4,900		$ 9,400
Effective Income Tax Reconciliation, Transition Tax		12.10%		5.30%
Unrecognized Tax Benefits, Period Increase (Decrease)			$ 56,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Thousands	Jun. 29, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
Business Combination, Contingent Consideration, Liability	$ 9,052

Common Stock Repurchases (Detai

Common Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Oct. 30, 2018
Common Stock Repurchases [Abstract]
Stock Repurchased During Period, Value			$ 201,500
Stock repurchase program, authorized amount					$ 1,500,000
Value of common stock repurchased	$ 107,957	$ 207,558	201,509	$ 320,056
Stock repurchase program, remaining authorized amount	$ 900,000		$ 900,000
Stock Repurchased During Period, Shares			3.5

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 0	$ 2,949
Business Combination, Contingent Consideration, Liability			$ 9,052
Goodwill	$ 532,251		$ 532,251

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Goodwill (Details) - USD ($) $ in Thousands	Dec. 28, 2019	Jun. 29, 2019
Goodwill [Line Items]
Goodwill	$ 532,251	$ 532,251

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Jun. 29, 2019
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	$ 619,115		$ 619,115		$ 616,325
Accumulated Amortization	570,606		570,606		562,873
Net	48,509		48,509		53,452
Intangible Assets, Gross	619,115		619,115		619,115
Total purchased intangible assets	48,509		48,509		56,242
Cost, Amortization	3,111	$ 6,868	6,221	$ 13,783
Intangible asset amortization	756	756	1,512	1,529
Intangible Asset Amortization Expense	3,867	$ 7,624	7,733	$ 15,312
Future amortization expense [Abstract]
Remaining three months of 2017	7,733		7,733
2019	13,767		13,767
2020	8,088		8,088
2021	7,604		7,604
2022	4,628		4,628
Thereafter	6,689		6,689
Net	48,509		48,509		53,452
Intellectual Property [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	490,136		490,136		487,346
Accumulated Amortization	451,780		451,780		445,558
Net	38,356		38,356		41,788
Future amortization expense [Abstract]
Net	38,356		38,356		41,788
Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	116,505		116,505		116,505
Accumulated Amortization	107,244		107,244		105,901
Net	9,261		9,261		10,604
Future amortization expense [Abstract]
Net	9,261		9,261		10,604
Tradename [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	9,974		9,974		9,974
Accumulated Amortization	9,082		9,082		8,914
Net	892		892		1,060
Future amortization expense [Abstract]
Net	892		892		1,060
Patents [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	2,500		2,500		2,500
Accumulated Amortization	2,500		2,500		2,500
Net	0		0		0
Future amortization expense [Abstract]
Net	0		0		0
In Process Research and Development [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
IPR&D	$ 0		$ 0		$ 2,790

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Long Lived Assets Held-for-sale [Line Items]
Impairment of long-lived assets	$ 0	$ 753	$ 0	$ 753
Gain (Loss) on Disposition of Property Plant Equipment			$ (489)	$ (2,896)

Restructuring Activities (Detai

Restructuring Activities (Details) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Restructuring Cost and Reserve [Line Items]
Earnings per share, Diluted (per share)	$ 0.53	$ 0.47	$ 1.04	$ 1.17

Restructuring Activities Change

Restructuring Activities Change in Estimate (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ 169,056	$ 182,204	$ 325,060	$ 416,386
Net income	$ 146,050	$ 131,892	$ 286,206	$ 329,315
Basic	$ 0.54	$ 0.48	$ 1.06	$ 1.19
Diluted	$ 0.53	$ 0.47	$ 1.04	$ 1.17

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 29, 2018	Dec. 29, 2018	Dec. 28, 2019	Jun. 29, 2019	Jun. 24, 2017
Weighted Average Discount Rate [Line Items]
Operating Lease, Payments		$ 5,911
Operating Lease, Weighted Average Remaining Lease Term	7 years	7 years
Lessee, Operating Lease, Discount Rate	3.45%	3.45%
Operating Leases, Rent Expense	$ 2,900	$ 5,900
FixedRateNoteDueJune2027at3Point450Percent[Member] [Member]
Weighted Average Discount Rate [Line Items]
Leases, Interest Rate, Stated Percentage			3.45%	3.45%	3.45%

Leases Leases - Schedule of Mat

Leases Leases - Schedule of Maturities (Details) - USD ($) $ in Thousands	Dec. 28, 2019	Jun. 30, 2019
Leases - schedule of maturities [Abstract]
Lessee, Operating Lease, Liability, Payments, Due	$ 5,969
Lessee, Operating Lease, Liability, Payments, Due Year Two	11,818
Lessee, Operating Lease, Liability, Payments, Due Year Three	10,847
Lessee, Operating Lease, Liability, Payments, Due Year Four	9,599
Lessee, Operating Lease, Liability, Payments, Due Year Five	8,202
Lessee, Operating Lease, Liability, Payments, Due after Year Five	21,904
Lessee, Operating Lease, Liability, Payments, Due	68,339
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	7,657
Operating Lease, Liability	$ 60,682	$ 65,200

Leases Balance Sheet Items Rela

Leases Balance Sheet Items Related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 29, 2018	Dec. 29, 2018	Dec. 28, 2019	Jun. 30, 2019
Balance Sheet Items Related to Leases [Abstract]
Operating Leases, Rent Expense	$ 2,900	$ 5,900
Operating Lease, Right-of-Use Asset			$ 56,170	$ 61,000
Operating Lease, Liability, Current			10,028
Operating Lease, Liability, Noncurrent			$ 50,784

Uncategorized Items - maximq220

Label	Element	Value
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	$ 17,689,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	126,808,000
Adjustment to Retained Earnings ASU 2016-01	mxim_AdjustmenttoRetainedEarningsASU201601	(5,916,000)
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	21,702,000
Adjustments to Additional Paid in Capital, Other	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	3,471,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,912,323,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,930,940,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	131,892,000
Interest Paid, Excluding Capitalized Interest, Operating Activities	us-gaap_InterestPaidNet	$ 17,063,000
Stockholders' Equity, Other Shares	us-gaap_StockholdersEquityOtherShares	281,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	$ 7,235,000
AOCI Attributable to Parent [Member]
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	11,336,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(12,720,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(14,985,000)
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	17,689,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	7,235,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21,702,000
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(44,181,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(5,916,000)
Common Stock [Member]
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	$ 274,326,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	384,000
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	3,960,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	191,000
Retained Earnings [Member]
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	$ 126,808,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,924,764,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,945,646,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	131,892,000
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	$ (163,377,000)